WILLIAM GEBELE: Open Payments
NPI 1205111713 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$161 in 8 payments from 6 companies in 2025. Trend: 2023 $286 · 2024 $105 · 2025 $161
Food & beverage: $161
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $53 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| SERVIER PHARMACEUTICALS LLC | 1 | $24 |
| ABBVIE INC. | 1 | $23 |
| ARGENX US, INC. | 1 | $18 |
| Tanabe Pharma America, Inc. | 1 | $16 |
Products named: INGREZZA, PONVORY, Voranigo, QULIPTA, VYVGART HYTRULO, Radicava.
Industry payments across OH — which companies pay providers there.
